The Global Health Summit 2026, held in Hong Kong, focused on the translation of scientific breakthroughs into clinical practice and the promotion of biotechnology investments. Over 3,000 attendees from various sectors, including healthcare and technology, gathered to discuss advancements in clinical translation, artificial intelligence applications, oncology, and longevity science. The Hong Kong Investment Corporation emphasized the importance of long-term funding for the biotechnology and health technology sectors. The event also featured discussions on collaborative opportunities between Hong Kong and the Greater Bay Area to bring innovative therapies from labs to patients. In addition, a new organization, the Asia-Pacific Society for Brain-Computer Interface, was launched to support advancements in brain science and neuromodulation.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.biospectrumasia.com/news/26/28194/global-health-summit-2026-highlights-clinical-translation-and-biotech-investment-in-hong-kong.html
